A new fast-acting insulin aspart (FiASP) that allows patients to take the treatment immediately before a meal, will be listed on the PBS from 1 June for the treatment of type 1 diabetes. The product, marketed by Novo Nordisk, has a more rapid onset and shorter duration of insulin action, than previous insulin aspart formulations such as ...
New faster-acting insulin FiASP on PBS from 1 June
By David Rowley
15 May 2019